| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Reviews |
1 Cancer Growth and Translational Genetics, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana; 2 Wood Hudson Cancer Research Laboratory, Newport, Kentucky; and 3 Isis Pharmaceuticals, Carlsbad, California
Requests for reprints: Jeremy R. Graff, Cancer Growth and Translational Genetics, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, DC 0546, Indianapolis, IN 46285. Phone: 317-277-0220; Fax: 317-277-3652; E-mail: Graff_jeremy{at}lilly.com.
Key Words: antisense oligonucleotide • eIF4E • translational control
The eukaryotic translation initiation factor 4E (eIF4E) is frequently overexpressed in human cancers in relation to disease progression and drives cellular transformation, tumorigenesis, and metastatic progression in experimental models. Enhanced eIF4E function results from eIF4E overexpression and/or activation of the ras and phosphatidylinositol 3-kinase/AKT pathways and selectively increases the translation of key mRNAs involved in tumor growth, angiogenesis, and cell survival. Consequently, by simultaneously and selectively reducing the expression of numerous potent growth and survival factors critical for malignancy, targeting eIF4E for inhibition may provide an attractive therapy for many different tumor types. Recent work has now shown the plausibility of therapeutically targeting eIF4E and has resulted in the advance of the first eIF4E-specific therapy to clinical trials. These studies illustrate the increased susceptibility of tumor tissues to eIF4E inhibition and support the notion that the enhanced eIF4E function common to many tumor types may represent an Achilles' heel for cancer. [Cancer Res 2008;68(3):631–4]
This article has been cited by other articles:
|
|
 |
|
  Y. Y. Kim, L. Von Weymarn, O. Larsson, D. Fan, J. M. Underwood, M. S. Peterson, S. S. Hecht, V. A. Polunovsky, and P. B. Bitterman Eukaryotic Initiation Factor 4E Binding Protein Family of Proteins: Sentinels at a Translational Control Checkpoint in Lung Tumor Defense Cancer Res., November 1, 2009; 69(21): 8455 - 8462. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Fu, J. Kim, A. Vidrich, T. W. Sturgill, and S. M. Cohn Intestinal cell kinase, a MAP kinase-related kinase, regulates proliferation and G1 cell cycle progression of intestinal epithelial cells Am J Physiol Gastrointest Liver Physiol, October 1, 2009; 297(4): G632 - G640. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H Schulze-Bergkamen, A Weinmann, M Moehler, J Siebler, and P R Galle Novel ways to sensitise gastrointestinal cancer to apoptosis Gut, July 1, 2009; 58(7): 1010 - 1024. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Graff, B. W. Konicek, R. L. Lynch, C. A. Dumstorf, M. S. Dowless, A. M. McNulty, S. H. Parsons, L. H. Brail, B. M. Colligan, J. W. Koop, et al. eIF4E Activation Is Commonly Elevated in Advanced Human Prostate Cancers and Significantly Related to Reduced Patient Survival Cancer Res., May 1, 2009; 69(9): 3866 - 3873. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. E. O'Reilly, M. Warycha, M. A. Davies, V. Rodrik, X. K. Zhou, H. Yee, D. Polsky, A. C. Pavlick, N. Rosen, N. Bhardwaj, et al. Phosphorylated 4E-BP1 Is Associated with Poor Survival in Melanoma Clin. Cancer Res., April 15, 2009; 15(8): 2872 - 2878. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. T. Coleman, R. Bigelow, and J. A. Cardelli Inhibition of fatty acid synthase by luteolin post-transcriptionally down-regulates c-Met expression independent of proteosomal/lysosomal degradation Mol. Cancer Ther., January 1, 2009; 8(1): 214 - 224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Welch, C. R. Cooper, D. R. Hurst, C. C. Lynch, M. D. Martin, K. S. Vaidya, M. N. VanSaun, and A. M. Mastro Metastasis Research Society-American Association for Cancer Research Joint Conference on Metastasis Cancer Res., December 1, 2008; 68(23): 9578 - 9582. [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Mills, Y. Hippo, F. Robert, S. M. H. Chen, A. Malina, C.-J. Lin, U. Trojahn, H.-G. Wendel, A. Charest, R. T. Bronson, et al. mTORC1 promotes survival through translational control of Mcl-1 PNAS, August 5, 2008; 105(31): 10853 - 10858. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. C. Prendergast Murder or Suicide: Strategies to Selectively Eliminate Cancer Cells Cancer Reviews Online Content, March 1, 2008; 2008(3): 5 - 6. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
